Adagio Medical Holdings, Inc. (ADGM)
0.099
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
0.095
0.00 (0.00%)
After-Hours: 20:00
Adagio Medical Holdings Enterprise Value : 20.46M for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 20.46M |
| October 15, 2026 | 20.55M |
| October 14, 2026 | 20.24M |
| October 13, 2026 | 21.04M |
| October 12, 2026 | 21.19M |
| October 09, 2026 | 21.15M |
| October 08, 2026 | 21.15M |
| October 07, 2026 | 21.23M |
| October 06, 2026 | 21.33M |
| October 05, 2026 | 21.39M |
| October 02, 2026 | 21.66M |
| October 01, 2026 | 21.73M |
| September 30, 2026 | 21.66M |
| September 29, 2026 | 21.46M |
| September 28, 2026 | 22.05M |
| September 25, 2026 | 22.59M |
| September 24, 2026 | 22.93M |
| September 23, 2026 | 23.32M |
| September 22, 2026 | 29.04M |
| September 21, 2026 | 29.43M |
| September 18, 2026 | 28.98M |
| September 17, 2026 | 29.81M |
| September 16, 2026 | 29.34M |
| September 15, 2026 | 28.52M |
| September 14, 2026 | 28.27M |
| Date | Value |
|---|---|
| September 11, 2026 | 30.72M |
| September 10, 2026 | 31.14M |
| September 09, 2026 | 31.70M |
| September 08, 2026 | 31.75M |
| September 04, 2026 | 30.79M |
| September 03, 2026 | 30.27M |
| September 02, 2026 | 30.03M |
| September 01, 2026 | 29.64M |
| August 31, 2026 | 30.00M |
| August 28, 2026 | 29.61M |
| August 27, 2026 | 29.82M |
| August 26, 2026 | 29.85M |
| August 25, 2026 | 30.48M |
| August 24, 2026 | 31.37M |
| August 21, 2026 | 32.68M |
| August 20, 2026 | 32.34M |
| August 19, 2026 | 32.30M |
| August 18, 2026 | 32.61M |
| August 17, 2026 | 32.73M |
| August 14, 2026 | 33.64M |
| August 13, 2026 | 33.59M |
| August 12, 2026 | 33.59M |
| August 11, 2026 | 34.23M |
| August 10, 2026 | 34.79M |
| August 07, 2026 | 33.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 209.16B |
| AngioDynamics, Inc. | 453.62M |
| Alphatec Holdings, Inc. | 2.106B |
| AtriCure, Inc. | 2.758B |
| Baxter International, Inc. | 19.75B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.717M |
| Total Expenses (Quarterly) | 6.717M |
| EPS Diluted (Quarterly) | -0.3024 |
| Earnings Yield | -1.45K% |
| Normalized Earnings Yield | -1257.07 |